Skip to content

Silicone compared to polyvinyl chloride ring pessary in the treatment of vaginal prolapse

Silicone vs polyvinyl chloride (PVC) ring pessary for pelvic organ prolapse: a randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10774395
Enrollment
200
Registered
2025-09-01
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of patients with pelvic organ prolapse using vaginal ring pessary Urological and Genital Diseases

Interventions

Recruitment Patient recruitment will take place in the Gynaecology Clinic of Universiti Malaya Medical Centre (UMMC). The Eligibility Assessment Form containing study inclusion and exclusion criteria

Sponsors

Early Career Research Grant (ECRG) Bahagian Pengurusan Geran Penyelidikan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Symptomatic stage 1 to Stage 4 POP (using the POP-Q system assessment) 2. Shared decision for a vaginal ring pessary to treat POP 3. Never before used a vaginal pessary for POP treatment

Exclusion criteria

Exclusion criteria: 1. Existing vaginal or vulvar lacerations / ulcers 2. Vaginal infection 3. Previous vaginal repair surgery (not including childbirth-related perineal repair) 4. Postmenopausal bleeding in the last 6 months (if not fully investigated) 5. Abnormal cervical screening (if not fully investigated)

Design outcomes

Primary

MeasureTime frame
1. Participants’ satisfaction with the pessary fitting process (after successful fitting, at end of clinic visit), using an 11-point 0-10 Numeric Rating Scale (NRS) [higher score, greater satisfaction] (by participants) 2. Participants’ satisfaction with pessary use, using an 11-point 0-10 NRS [higher score, greater satisfaction] (at three months follow up) (by participants)

Secondary

MeasureTime frame
At the end of clinic visit, record 1. Successful fitting (by provider) 2. Make of successfully-fitted pessary (by provider) 3. Participants’ pain score associated with insertion using an 11-point 0-10 NRS [higher score, greater pain] (by participants) 4. Number of fitting attempts (until successful fitting) (by provider) 5. Ease of insertion using an 11-point 0-10 NRS [higher score, greater ease] (by provider) 6. Ring diameter of successfully-fitted pessary (by provider) At three months follow up, record 7. Pessary discontinuation and reason (by participants) 8. Pessary make in use (by provider) 9. Adverse interim symptoms during first three months after pessary insertion using a 4-grade Likert scale (by participants): 9.1. Bothersome vaginal discharge 9.2. Vulva-vaginal itching 9.3. Vaginal bleeding 9.4. Pessary dislodged 9.5. I can feel the pessary 9.6. Pessary discomfort 10. Number of unscheduled pessary-related visits (by participants) 11. Prolapse Quality of Life (P-QOL) questionnaire (by participants) 12. Recommends allocated (PVC or silicone) ring pessary to a friend, using a 5-grade Likert scale (by participants) 13. Pessary removal 13.1. Participants’ pain score associated with removal using 0–10 NRS [higher score, greater pain] (by participants) 13.2. Ease of removal using 0–10 NRS [higher score, greater ease] (by provider) 13.3. Pessary condition: Reusable / Needs replacement (by provider) 14. Vulval and vaginal (speculum) examination after pessary removal (by provider) 14.1. Vaginal mucosal erosion / ulceration 14.2. Vaginal mucopurulent discharge 14.3. Vaginal foul / offensive odour 15. Major harms, if present (by provider) 15.1. Pessary retention requiring surgical release under anaesthesia 15.2. Lower genital laceration requiring surgical repair under anaesthesia 16. Stage of Pelvic Organ Prolapse using POP-Q (Pelvic Organ Prolapse Quantification) system (by provider) 17. Pessary insertio

Countries

Malaysia

Contacts

Public ContactAtiqa;Farah Abu Bakar;Mohd Faiz Gan

;

atiqa.bakar@ummc.edu.my;farahgan@um.edu.my+60 19-5188154;+60176345907

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026